Genetic instability as a consequence of inappropriate entry into and Progression through S-phase - Cancer and Metastasis Reviews
- ️Wahl, Geoffrey M.
- ️Wed Mar 01 1995
References
Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491–7495, 1992
Lane DP: Cancer. p53, guardian of the genome. Nature 358: 15–16, 1992
Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937–948, 1992
Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923–935, 1992
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304–6311, 1991
Di Leonardo A, Linke SP, Yin Y, Wahl GM: Cell cycle regulation of gene amplification. Cold Spring Harbor Symp Qaunt Biol 58: 655–667, 1994
Windle BE, Wahl GM: Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events. Mutat Res 276: 199–224, 1992
Denko NC, Giaccia AJ, Stringer JR, Stambrook PJ: The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc Natl Acad Sci USA 91: 5124–5128, 1994
Stark GR: Regulation and mechanisms of mammalian gene amplification. Adv Cancer Res 61: 87–113, 1993
Schaefer DI, Livanos EM, White AE, Tlsty TD: Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts. Cancer Res 53: 4946–4951, 1993
Tlsty TD: Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc Natl Acad Sci USA 87: 3132–3136, 1990
Wright JA, Smith HS, Watt FM, Hancock MC, Hudson DL, Stark GR: DNA amplification is rare in normal human cells. Proc Natl Acad Sci USA 87: 1791–1795, 1990
Blount PL, Meltzer SJ, Yin J, Huang Y, Krasna MJ, Reid BJ: Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci USA 90: 3221–3225, 1993
Maltzman W, Czyzyk L: UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4: 1689–1694, 1984
Hall PA, McKee PH, Menage HD, Dover R, Lane DP: High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8: 203–207, 1993
Fritsche M, Haessler C, Brandner G: Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8: 307–318, 1993
Donehower LA, Bradley A: The tumor suppressor p53. Biochim Biophys Acta 1155: 181–205, 1993
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701–704, 1993
Xiong Y, Zhang H, Beach D: Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7: 1572–1583, 1993
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805–816, 1993
El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169–1174, 1994
Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013–1023, 1994
Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993–1006, 1992
Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM: Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487–497, 1993
Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499–511, 1993
Dulic V, Drullinger LF, Lees E, Reed SI, Stein GH: Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci USA 90: 11034–11038, 1993
Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J: Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 260: 536–539, 1993
Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059–1065, 1993
Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 504–514, 1992
Li R, Waga S, Hannon GJ, Beach D, Stillman B: Differential effects of the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534–537, 1994
Dyson N, Howley PM, Munger K, Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934–937, 1989
Whyte P, Williamson NM, Harlow E: Cellular targets for transformation by the adenovirus E1A proteins. Cell 56: 67–75, 1989
DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM: SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275–283, 1988
Bagchi S, Weinmann R, Raychaudhuri P: The retinoblastoma protein copurifies with E2F-1, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65: 1063–1072, 1991
Chittenden T, Livingston DM, Kaelin WJ: The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65: 1073–1082, 1991
Johnson DG, Schwarz JK, Cress WD, Nevins JR: Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349–352, 1993
Farnham PJ, Slansky JE, Kollmar R: The role of E2F in the mammalian cell cycle. Biochim Biophys Acta 1155: 125–131, 1993
Nevins JR: E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424–429, 1992
Means AL, Farnham PJ: Transcriptional initiation from the dihydrofolate reductase promoter is positioned by HIP-1 binding at the initiation site. Mol Cell Biol 10: 653–661, 1990
Slansky JE, Li Y, Kaelin WG, Farnham PJ: A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol 13: 1610–1618, 1993
Blake MC, Azizkhan JC: Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase genein vitro andin vivo. Mol Cell Biol 9: 4994–5002, 1989
Johnson LF: Postranscriptional regulation of thymidylate synthase gene expression. J Cell Biochem 54: 387–392, 1994
Nevins JR: Cell cycle targets of the DNA tumor viruses. Curr Op Genet Dev 4: 130–134, 1994
Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288–294, 1992
Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA: Effects of an Rb mutation in the mouse. Nature 359: 295–300, 1992
Clarke AR, Maandag ER, Van RM, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H: Requirement for a functional Rb-1 gene in murine development. Nature 359: 328–330, 1992
Hartwell LH, Weinert TA: Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629–634, 1989
Di Leonardo A, Linke SP, Clarkin K, Wahl GM: DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8: 2540–2551, 1994
Nelson WG, Kastan MB: DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14: 1815–1823, 1994
Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90–98, 1994
Shay JW, Wright WE, Werbin H: Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1072: 1–7, 1991
Hall EJ:In: Radiobiology for the Radiobiologist (J.P. Lippicott Co., Philadelphia) 1994
Swyryd EA, Seaver SS, Stark GR: N-(phosphonacetyl)-Laspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture. J Biol Chem 249: 6945–6950, 1974
White AE, Livanos EM, Tlsty TD: Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 8: 666–677, 1994
Ardalan B, Ucar A, Reddy R, Livingstone AS, Markoe A, Schwade J, Richman SP, Donofrio K: Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas. Cancer 74: 1869–1873, 1994
Seiter K, Kemeny N, Martin D, Schneider A, Williams L, Colofiore J, Sawyer R: Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-aspartate, methotrexate, and leucovorin. Cancer 71: 1875–1881, 1993
Slebos RJ, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hedrick L, Kastan MB, Cho KR: p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci USA 91: 5320–5324, 1994
Pardee AB: G1 events and regulation of cell proliferation. Science 246: 603, 1989
Dulic V, Lees E, Reed SI: Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958–1961, 1992
Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM: Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257: 1689–1694, 1992
Ewen ME, Ludlow JW, Marsilio E, DeCaprio JA, Millikan RC, Cheng SH, Paucha E, Livingston DM: An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell 58: 257–267, 1989
Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA: Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev 7: 2392–2404, 1993
Hannon GJ, Demetrick D, Beach D: Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7: 2378–2391, 1993
Li Y, Graham C, Lacy S, Duncan AM, Whyte P: The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7: 2366–2377, 1993
Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, Wahl GM: pRb deficiency leads to inappropriate entry into S phase, activation of E2F responsive genes and apoptosis. Proc Natl Acad Sci USA: in press, 1995
Gaudray P, Trotter J, Wahl G: Fluorescent methotrexate labeling and flow cytometric analysis of cells containing low levels of dihydrofolate reductase. J Bio Chem 261: 6285–6292, 1986
Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849–852, 1993
Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847–849, 1993
Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957–967, 1993
Kaminskas E: Effects of methotrexate on ribonucleotide pools in growing and in growth-arrested tumor cells and antagonism by RNA synthesis inhibitors. J Biol Chem 257: 4279–4284, 1982
Unger C, Kress S, Buchmann A, Schwarz M: Gamma-irradiation-induced micronuclei from mouse hepatoma cells accumulate high levels of the tumor suppressor protein p53. Cancer Res 54: 3651–3655, 1994
Howes KA, Ransom N, Papermaster DS, Lasudry JGH, Albert DM, Windle JJ: Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 8: 1300–1310, 1994
Pan H, Griep AE: Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor supressor gene function in development. Genes Dev 8: 1285–1299, 1994
Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72–74, 1994
Lee EY, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, Herrup K: Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev 8: 2008–2021, 1994
Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T: p53-dependent apoptosis supresses tumor growth and progressionin vivo. Cell 78: 703–711, 1994
Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114–10118, 1992
Greider CW: Telomeres, telomerase and senescence. Bioessays 12: 363–369, 1990
Rathmell WK, Chu G: Involvement of the Ku autoantigen in the cellular response to DNA double-strand breaks. Proc Natl Acad Sci USA 91: 7623–7627, 1994
Lees MS, Chen YR, Anderson CW: Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol Cell Biol 10: 6472–6481, 1990
Bakalkin G, Yakovleva T, Selivanova G, Magnusson KP, Szekely L, Kiseleva E, Klein G, Terenius L, Wiman KG: p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc Natl Acad Sci USA 91: 413–417, 1994
Caelles C, Helmberg A, Karin M: p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220–223, 1994
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825, 1993
Tokina T, Thiagalingam S, El-Deiry W, Waldman T, Kinzler K, Vogelstein B: p53 tagged sites from human genomic DNA Hum Mol Genet 3: 1537–1542, 1994
Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9: 707–718, 1994
Musgrove EA, Lee CS, Buckley MF, Sutherland RL: Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA 91: 8022–8026, 1994
Resnitzky D, Gossen M, Bujard H, Reed SI: Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14: 1669–1679, 1994
Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar SD, Roussel MF, Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7: 1559–1571, 1993
Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT: Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53: 5535–5541, 1993
Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP: Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53: 2736–2739, 1993
Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP: Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 54: 4299–4303, 1994
Foster PL, Trimarchi JM: Adaptive reversion of a frameshift mutation in Escherichia coli by simple base deletions in homopolymeric runs. Science 265: 407–409, 1994
Rosenberg SM, Longerich S, Gee P, Harris RS:Adaptive mutation by deletions in small mononucleotide repeats. Science 265: 405–407, 1994
Chen L, Nishinaka T, Kwan K, Kitabayashi I, Yokoyama K, Fu Y, Grunwald S, Chiu R: The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol Cell Biol 4380-4389, 1994
Welch PJ, Wang JYJ: A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75: 779–790, 1993
Wilcock D, Lane DP: Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. Nature 349: 429–431, 1991
Karantza V, Maroo A, Fay D, Sedivy JM: Overproduction of Rb protein after the G1/S boundary causes G2 arrest. Mol Cell Biol 13: 6640–6652, 1993
Miyashita T, Harigai M, Hanada M, Reed JC: Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131–3135, 1994
Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D: Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9: 1791–1798, 1994
Hunter T, Pines J: Cyclins and cancer II: cyclin D and cyclin-dependent kinase inhibitors come of age. Cell 79: 573–582, 1994